XML 37 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Premiums $ 257,157 $ 226,233 $ 201,478
Investment and other income 2,030 2,324 1,502
Total revenues 324,162 287,597 257,141
Operating costs:      
Medical costs 210,842 186,911 159,396
Operating costs 47,782 42,579 41,704
Cost of products sold 33,703 31,034 30,745
Depreciation and amortization 3,400 3,103 2,891
Total operating costs 295,727 263,627 234,736
Earnings from operations 28,435 23,970 22,405
Interest expense (2,092) (1,660) (1,663)
Earnings before income taxes 26,343 22,310 20,742
Provision for income taxes (5,704) (4,578) (4,973)
Net earnings 20,639 17,732 15,769
Earnings attributable to noncontrolling interests (519) (447) (366)
Net earnings attributable to UnitedHealth Group common shareholders $ 20,120 $ 17,285 $ 15,403
Earnings per share attributable to UnitedHealth Group common shareholders:      
Basic $ 21.47 $ 18.33 $ 16.23
Diluted $ 21.18 $ 18.08 $ 16.03
Basic weighted-average number of common shares outstanding 937 943 949
Dilutive effect of common share equivalents 13 13 12
Diluted weighted-average number of common shares outstanding 950 956 961
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 3 1 8
Products      
Revenue from Products and Services $ 37,424 $ 34,437 $ 34,145
Services      
Revenue from Products and Services $ 27,551 $ 24,603 $ 20,016